Medtronic PLC (Germany) Today
| 2M6 Stock | 81.39 0.24 0.30% |
Performance3 of 100
| Odds Of DistressLess than 9
|
Medtronic PLC is selling for under 81.39 as of the 27th of November 2024; that is 0.30 percent increase since the beginning of the trading day. The stock's last reported lowest price was 81.19. Medtronic PLC has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat insignificant performance during the last 90 days. Equity ratings for Medtronic PLC are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of December 2023 and ending today, the 27th of November 2024. Click here to learn more.
Moving against Medtronic Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Medtronic Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Medtronic PLC's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Medtronic PLC or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman CEO | Geoffrey Martha |
Medtronic PLC (2M6) is traded on XETRA Stock Exchange in Germany and employs 95,000 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 102.34 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Medtronic PLC's market, we take the total number of its shares issued and multiply it by Medtronic PLC's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Medtronic PLC has 1.33 B outstanding shares.
Medtronic PLC generates positive cash flow from operations, but has no cash available
Check Medtronic PLC Probability Of Bankruptcy
Ownership AllocationMedtronic PLC maintains a total of 1.33 Billion outstanding shares. The majority of Medtronic PLC outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Medtronic PLC to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Medtronic PLC. Please pay attention to any change in the institutional holdings of Medtronic PLC as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Medtronic Ownership Details
Medtronic PLC Risk Profiles
Although Medtronic PLC's alpha and beta are two of the key measurements used to evaluate Medtronic PLC's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.8471 | |||
| Semi Deviation | 1.09 | |||
| Standard Deviation | 1.11 | |||
| Variance | 1.24 |
Medtronic Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Medtronic PLC without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Rebalancing Now
Portfolio RebalancingAnalyze risk-adjusted returns against different time horizons to find asset-allocation targets |
| All Next | Launch Module |
Medtronic PLC Corporate Management
Elected by the shareholders, the Medtronic PLC's board of directors comprises two types of representatives: Medtronic PLC inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medtronic. The board's role is to monitor Medtronic PLC's management team and ensure that shareholders' interests are well served. Medtronic PLC's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medtronic PLC's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ryan Weispfenning | VP Relations | Profile | |
| Ivan Fong | Gen VP | Profile | |
| Sean Lennon | Chief Officer | Profile | |
| Jennifer Kirk | Global Officer | Profile | |
| Robert White | Ex Portfolio | Profile | |
| Robert Hoedt | Ex Regions | Profile |
Additional Tools for Medtronic Stock Analysis
When running Medtronic PLC's price analysis, check to measure Medtronic PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic PLC is operating at the current time. Most of Medtronic PLC's value examination focuses on studying past and present price action to predict the probability of Medtronic PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic PLC's price. Additionally, you may evaluate how the addition of Medtronic PLC to your portfolios can decrease your overall portfolio volatility.